Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
# | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|
---|---|---|---|---|---|---|---|
4501 | M1.ON.12.118 | 101428 | Apoptosis |
M 1
|
E
|
||
4502 | M1.MC.12.5 | 101464 | Viridans Group Streptococci |
M 1
|
E
|
||
4503 | M1.GI.12.143 | 101200 | Staphylococcus aureus |
M 1
|
E
|
||
4504 | M1.IM.12.13 | 100434 | Immunization |
M 1
|
E
|
||
4505 | M1.IM.15.74 | 106668 | Cells of the Immune System |
M 1
|
E
|
||
4506 | M1.MC.12.195 | 101654 | Bacillus anthracis |
M 1
|
E
|
||
4507 | M1.BC.12.65 | 100130 | Protein Synthesis |
M 1
|
E
|
||
4508 | M1.MC.12.18 | 101477 | Immunization |
M 1
|
E
|
||
4509 | M1.BC.12.4697 | 108127 | Galactose Metabolism |
M 2
|
E
|
||
4510 | M1.ON.12.55 | 101365 | Hereditary Spherocytosis |
M 1
|
E
|
||
4511 | M1.ON.12.70 | 101380 | Hereditary Spherocytosis |
M 1
|
E
|
||
4512 | M1.RP.12.12 | 101906 | Oogenesis |
M 1
|
E
|
||
4513 | M1.ON.12.4699 | 108388 | Basal Cell Carcinoma of the Skin |
M 2
|
E
|
||
4514 | M1.GI.12.36 | 101093 | Proton Pump Inhibitors |
M 1
|
E
|
||
4515 | M1.EB.12.4694 | 107897 | Germ Layer Derivatives |
M 1
|
E
|
||
4516 | M1.ON.12.136 | 101446 | Ondansetron |
M 1
|
E
|
||
4517 | M1.ON.12.4699 | 108298 | Benign Bone Tumors |
M 2
|
E
|
||
4518 | M1.BC.12.89 | 100154 | Oxygen Transport and Hemoglobin |
M 1
|
E
|
||
4519 | M1.NE.12.4698 | 108261 | Parkinson Disease |
M 2
|
E
|
||
4520 | M1.MC.12.84 | 101543 | Streptococcus agalactiae (Group B Streptococci) |
M 1
|
E
|
||
4521 | M1.EC.12.46 | 100347 | Pituitary Apoplexy |
M 1
|
E
|
||
4522 | M1.EC.12.36 | 100337 | Addison Disease |
M 1
|
E
|
||
4523 | M1.EC.12.55 | 100356 | Diabetes Insipidus |
M 1
|
E
|
||
4524 | M1.EC.12.95 | 100396 | Addison Disease |
M 1
|
E
|
||
4525 | M1.EC.12.76 | 100377 | Hyperparathyroidism |
M 1
|
E
|
||
4526 | M1.EC.12.24 | 100325 | Hypercalcemia |
M 1
|
E
|
||
4527 | M1.EC.12.111 | 100412 | Hypercalcemia |
M 1
|
E
|
||
4528 | M1.EC.12.93 | 100394 | Thyroid Cancer |
M 1
|
E
|
||
4529 | M1.BC.12.4695 | 108004 | Glycogen |
M 1
|
E
|
||
4530 | M1.BC.12.4695 | 108017 | Glycogen |
M 2
|
E
|
||
4531 | M1.EC.12.97 | 100398 | Metabolic Syndrome |
M 1
|
E
|
||
4532 | M1.EC.12.59 | 100360 | Diabetes Drugs |
M 1
|
E
|
||
4533 | M1.EC.12.86 | 100387 | Hypoglycemia |
M 1
|
E
|
||
4534 | M1.BC.12.4695 | 107980 | Lipoprotein Disorders |
M 1
|
E
|
||
4535 | M1.BC.12.40 | 100105 | Ketone Bodies |
M 1
|
E
|
||
4536 | M1.BC.12.4695 | 108016 | Fatty Acid Metabolism |
M 2
|
E
|
||
4537 | M1.RP.12.4699 | 108294 | Fibrocystic Change |
M 2
|
E
|
||
4538 | M1.RP.12.27 | 101245 | Ectopic Pregnancy |
M 1
|
E
|
||
4539 | M1.IM.12.62 | 100483 | Chediak-Higashi Syndrome |
M 1
|
E
|
||
4540 | M1.BC.12.94 | 100159 | Type of DNA Mutations |
M 1
|
E
|
||
4541 | M1.RP.12.69 | 101287 | Mifepristone (RU-486) |
M 1
|
E
|
||
4542 | M1.GI.12.65 | 101122 | Anti-Platelet Drugs |
M 1
|
E
|
||
4543 | M1.GI.12.170 | 101227 | Fulminant Liver Failure |
M 1
|
E
|
||
4544 | M1.GI.12.175 | 101232 | Cirrhosis and Portal Hypertension |
M 1
|
E
|
||
4545 | M1.RP.12.24 | 101242 | Trimethoprim |
M 1
|
E
|
||
4546 | M1.GI.12.11 | 101068 | Anti-Platelet Drugs |
M 1
|
E
|
||
4547 | M1.GI.12.14 | 101071 | Ulcerative Colitis |
M 1
|
E
|
||
4548 | M1.GI.12.15 | 101072 | Acute Pancreatitis |
M 1
|
E
|
||
4549 | M1.GI.12.34 | 101091 | Anti-Platelet Drugs |
M 1
|
E
|
||
4550 | M1.GI.12.43 | 101100 | Anti-Platelet Drugs |
M 1
|
E
|
||
4551 | M1.GI.12.53 | 101110 | Anti-Platelet Drugs |
M 1
|
E
|
||
4552 | M1.GI.12.56 | 101113 | Colonic Polyps |
M 1
|
E
|
||
4553 | M1.GI.12.129 | 101186 | Primary Biliary Cholangitis |
M 1
|
E
|
||
4554 | M1.GI.12.133 | 101190 | Cholelithiasis |
M 1
|
E
|
||
4555 | M1.GI.12.140 | 101197 | Dubin-Johnson / Rotor Syndrome |
M 1
|
E
|
||
4556 | M1.GI.12.142 | 101199 | Hepatitis A Virus |
M 1
|
E
|
||
4557 | M1.GI.12.147 | 101204 | Hepatic Adenoma |
M 1
|
E
|
||
4558 | M1.GI.12.153 | 101210 | Acute Cholecystitis |
M 1
|
E
|
||
4559 | M1.GI.12.79 | 101136 | Anti-Platelet Drugs |
M 1
|
E
|
||
4560 | M1.GI.12.87 | 101144 | Acute Pancreatitis |
M 1
|
E
|
||
4561 | M1.GI.12.93 | 101150 | Crohn Disease |
M 1
|
E
|
||
4562 | M1.GI.12.96 | 101153 | Octreotide |
M 1
|
E
|
||
4563 | M1.RP.12.32 | 101250 | Hernias |
M 1
|
E
|
||
4564 | M1.RP.12.36 | 101254 | Chlamydia trachomatis |
M 1
|
E
|
||
4565 | M1.RP.12.37 | 101255 | Nephrolithiasis |
M 1
|
E
|
||
4566 | M1.RP.12.42 | 101260 | Penicillin |
M 1
|
E
|
||
4567 | M1.RP.12.53 | 101271 | Renal Cell Carcinoma |
M 1
|
E
|
||
4568 | M1.GI.12.111 | 101168 | Anti-Virals |
M 1
|
E
|
||
4569 | M1.GI.12.113 | 101170 | Anti-Platelet Drugs |
M 1
|
E
|
||
4570 | M1.GI.12.116 | 101173 | Cholelithiasis |
M 1
|
E
|
||
4571 | M1.GI.12.119 | 101176 | Anti-Platelet Drugs |
M 1
|
E
|
||
4572 | M1.GI.12.120 | 101177 | Hepatitis B Virus |
M 1
|
E
|
||
4573 | M1.MK.15.75 | 106853 | Systemic Lupus Erythematosus |
M 2
|
E
|
||
4574 | M1.RL.15.75 | 106763 | Hydronephrosis |
M 2
|
E
|
||
4575 | M1.MK.15.75 | 106803 | Osteoporosis |
M 2
|
E
|
||
4576 | M1.PY.12.75 | 106751 | Alcohol Withdrawal |
M 2
|
E
|
||
4577 | M1.CV.12.164 | 100680 | Contact us |
M 1
|
E
|
||
4578 | M1.CV.12.167 | 100683 | Contact us |
M 1
|
E
|
||
4579 | M1.CV.12.169 | 100685 | Contact us |
M 1
|
E
|
||
4580 | M1.CV.12.172 | 100688 | Contact us |
M 1
|
E
|
||
4581 | M1.CV.12.178 | 100694 | Contact us |
M 1
|
E
|
||
4582 | M1.CV.12.179 | 100695 | Contact us |
M 1
|
E
|
||
4583 | M1.CV.12.180 | 100696 | Contact us |
M 1
|
E
|
||
4584 | M1.CV.12.182 | 100698 | Contact us |
M 1
|
E
|
||
4585 | M1.CV.12.183 | 100699 | Contact us |
M 1
|
E
|
||
4586 | M1.CV.12.184 | 100700 | Contact us |
M 1
|
E
|
||
4587 | M1.CV.12.185 | 100701 | Contact us |
M 1
|
E
|
||
4588 | M1.CV.12.197 | 100713 | Contact us |
M 1
|
E
|
||
4589 | M1.CV.12.198 | 100714 | Contact us |
M 1
|
E
|
||
4590 | M1.CV.13.98 | 100614 | Angina |
M 2
|
E
|
||
4591 | M1.CV.12.155 | 100671 | Contact us |
M 1
|
E
|
||
4592 | M1.CV.12.156 | 100672 | Contact us |
M 1
|
E
|
||
4593 | M1.CV.12.157 | 100673 | Contact us |
M 1
|
E
|
||
4594 | M1.CV.12.87 | 100603 | Contact us |
M 1
|
E
|
||
4595 | M1.CV.12.199 | 100715 | Contact us |
M 1
|
E
|
||
4596 | M1.CV.12.210 | 100726 | Contact us |
M 1
|
E
|
||
4597 | M1.CV.12.214 | 100730 | Contact us |
M 1
|
E
|
||
4598 | M1.CV.12.216 | 100732 | Contact us |
M 1
|
E
|
||
4599 | M1.CV.12.227 | 100743 | Contact us |
M 1
|
E
|
||
4600 | M1.CV.12.228 | 100744 | Contact us |
M 1
|
E
|
||
4601 | M1.CV.12.230 | 100746 | Contact us |
M 1
|
E
|
||
4602 | M1.CV.12.236 | 100752 | Contact us |
M 1
|
E
|
||
4603 | M1.CV.12.237 | 100753 | Contact us |
M 1
|
E
|
||
4604 | M1.CV.12.239 | 100755 | Contact us |
M 1
|
E
|
||
4605 | M1.CV.12.243 | 100759 | Contact us |
M 1
|
E
|
||
4606 | M1.CV.12.244 | 100760 | Contact us |
M 1
|
E
|
||
4607 | M1.CV.12.261 | 100777 | Contact us |
M 1
|
E
|
||
4608 | M1.CV.12.265 | 100781 | Contact us |
M 1
|
E
|
||
4609 | M1.CV.12.266 | 100782 | Contact us |
M 1
|
E
|
||
4610 | M1.IM.12.12 | 100433 | Anti-Platelet Drugs |
M 1
|
E
|
||
4611 | M1.EC.12.100 | 100401 | Anti-Platelet Drugs |
M 1
|
E
|
||
4612 | M1.EB.12.33 | 100454 | Branchial Apparatus |
M 1
|
E
|
||
4613 | M1.IM.12.28 | 100449 | Anti-Platelet Drugs |
M 1
|
E
|
||
4614 | M1.EC.12.85 | 100386 | Anti-Platelet Drugs |
M 1
|
E
|
||
4615 | M1.EC.12.18 | 100319 | Anti-Platelet Drugs |
M 1
|
E
|
||
4616 | M1.OMB.67 | 106464 | a |
E
|
|||
4617 | M1.ST.12.27 | 100027 | Depression |
M 1
|
E
|
||
4618 | M1.ST.12.30 | 100030 | Medical Error Analysis |
M 1
|
E
|
||
4619 | M1.ST.12.45 | 100045 | Obsessive-Compulsive Disorder |
M 1
|
E
|
||
4620 | M1.ST.12.48 | 100048 | Legal Principles |
M 1
|
E
|
||
4621 | M1.ST.12.54 | 100054 | Sleep Apnea |
M 1
|
E
|
||
4622 | M1.ST.12.59 | 100059 | Ethical Principles |
M 1
|
E
|
||
4623 | M1.IM.15.74 | 106661 | Cell-Mediated Immunity |
M 1
|
E
|
||
4624 | M1.MC.12.197 | 101656 | Anti-Platelet Drugs |
M 1
|
E
|
||
4625 | M1.MC.12.198 | 101657 | Anti-Platelet Drugs |
M 1
|
E
|
||
4626 | M1.MC.12.199 | 101658 | Anti-Platelet Drugs |
M 1
|
E
|
||
4627 | M1.MC.12.200 | 101659 | Anti-Platelet Drugs |
M 1
|
E
|
||
4628 | M1.MC.12.97 | 101556 | Hepatitis E Virus |
M 1
|
E
|
||
4629 | M1.MC.12.100 | 101559 | Microbiology of Pneumonia |
M 1
|
E
|
||
4630 | M1.MC.12.116 | 101575 | Rhinovirus |
M 1
|
E
|
||
4631 | M1.MC.12.120 | 101579 | Hepatitis B Virus |
M 1
|
E
|
||
4632 | M1.MC.12.122 | 101581 | Opportunistic Mycoses |
M 1
|
E
|
||
4633 | M1.MC.12.133 | 101592 | Campylobacter jejuni |
M 1
|
E
|
||
4634 | M1.MC.12.134 | 101593 | Rhinovirus |
M 1
|
E
|
||
4635 | M1.MC.12.140 | 101599 | Hepatitis B Virus |
M 1
|
E
|
||
4636 | M1.MC.12.146 | 101605 | Parvovirus B19 |
M 1
|
E
|
||
4637 | M1.MC.12.154 | 101613 | Parvovirus B19 |
M 1
|
E
|
||
4638 | M1.MC.12.156 | 101615 | Systemic Mycoses |
M 1
|
E
|
||
4639 | M1.MC.12.160 | 101619 | Special Culture Requirements |
M 1
|
E
|
||
4640 | M1.MC.12.178 | 101637 | Epstein-Barr Virus |
M 1
|
E
|
||
4641 | M1.MC.12.186 | 101645 | HSV Type 1 |
M 1
|
E
|
||
4642 | M1.MC.12.85 | 101544 | Hepatitis B Virus |
M 1
|
E
|
||
4643 | M1.MC.12.90 | 101549 | Hepatitis A Virus |
M 1
|
E
|
||
4644 | M1.MC.12.77 | 101536 | Opportunistic Mycoses |
M 1
|
E
|
||
4645 | M1.MC.12.82 | 101541 | Microbiology of Urinary Tract Infections |
M 1
|
E
|
||
4646 | M1.MC.12.164 | 101623 | Human Papilloma Virus |
M 1
|
E
|
||
4647 | M1.MC.12.171 | 101630 | Gardnerella vaginalis |
M 1
|
E
|
||
4648 | M1.MK.12.4666 | 107101 | Duchenne and Becker Muscular Dystrophy |
M 2
|
E
|
||
4649 | M1.NE.12.4671 | 107143 | Blood-Brain Barrier |
M 1
|
E
|
||
4650 | M1.NE.12.4671 | 107144 | Blood-Brain Barrier |
M 1
|
E
|